TY - JOUR
T1 - A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19
AU - Yeo, Joo Guan
AU - Leong, Jing Yao
AU - Tay, Shi Huan
AU - Nadua, Karen Donceras
AU - Anderson, Danielle E.
AU - Lim, Amanda Jin Mei
AU - Ng, Xiang Wen
AU - Poh, Su Li
AU - Guo, Dianyan
AU - Yaung, Katherine Nay
AU - Kumar, Pavanish
AU - Wasser, Martin
AU - Hazirah, Sharifah Nur
AU - Sutamam, Nursyuhadah
AU - Chua, Camillus Jian Hui
AU - Qui, Martin
AU - Foo, Randy
AU - Gamage, Akshamal Mihiranga
AU - Yeo, Kee Thai
AU - Ramakrishna, Lakshmi
AU - Arkachaisri, Thaschawee
AU - Young, Barnaby E.
AU - Lye, David Chien
AU - Wang, Lin Fa
AU - Chong, Chia Yin
AU - Tan, Natalie Woon Hui
AU - Li, Jiahui
AU - Kam, Kai Qian
AU - Ginhoux, Florent
AU - Thoon, Koh Cheng
AU - Chan, Jerry Kok Yen
AU - Yung, Chee Fu
AU - Albani, Salvatore
N1 - Publisher Copyright:
© Copyright © 2021 Yeo, Leong, Tay, Nadua, Anderson, Lim, Ng, Poh, Guo, Yaung, Kumar, Wasser, Hazirah, Sutamam, Chua, Qui, Foo, Gamage, Yeo, Ramakrishna, Arkachaisri, Young, Lye, Wang, Chong, Tan, Li, Kam, Ginhoux, Thoon, Chan, Yung and Albani.
PY - 2021/5/25
Y1 - 2021/5/25
N2 - An accurate depiction of the convalescent COVID-19 immunome will help delineate the immunological milieu crucial for disease resolution and protection. Using mass cytometry, we characterized the immune architecture in patients recovering from mild COVID-19. We identified a virus-specific immune rheostat composed of an effector T (Teff) cell recall response that is balanced by the enrichment of a highly specialized regulatory T (Treg) cell subset. Both components were reactive against a peptide pool covering the receptor binding domain (RBD) of the SARS-CoV-2 spike glycoprotein. We also observed expansion of IFNγ+ memory CD4+ T cells and virus-specific follicular helper T (TFH) cells. Overall, these findings pinpoint critical immune effector and regulatory mechanisms essential for a potent, yet harmless resolution of COVID-19 infection.
AB - An accurate depiction of the convalescent COVID-19 immunome will help delineate the immunological milieu crucial for disease resolution and protection. Using mass cytometry, we characterized the immune architecture in patients recovering from mild COVID-19. We identified a virus-specific immune rheostat composed of an effector T (Teff) cell recall response that is balanced by the enrichment of a highly specialized regulatory T (Treg) cell subset. Both components were reactive against a peptide pool covering the receptor binding domain (RBD) of the SARS-CoV-2 spike glycoprotein. We also observed expansion of IFNγ+ memory CD4+ T cells and virus-specific follicular helper T (TFH) cells. Overall, these findings pinpoint critical immune effector and regulatory mechanisms essential for a potent, yet harmless resolution of COVID-19 infection.
KW - COVID-19
KW - SARS-CoV-2
KW - follicular helper T cells
KW - mass cytometry
KW - regulatory T cells
UR - http://www.scopus.com/inward/record.url?scp=85107378161&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2021.674279
DO - 10.3389/fimmu.2021.674279
M3 - Article
C2 - 34113347
AN - SCOPUS:85107378161
SN - 1664-3224
VL - 12
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 674279
ER -